![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Fingleton Barbara
Publisher: Informa Healthcare
E-ISSN: 1744-7631|7|3|385-397
ISSN: 1472-8222
Source: Expert Opinion on Therapeutic Targets, Vol.7, Iss.3, 2003-06, pp. : 385-397
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Matrix metalloproteinase inhibitors and cancer
By Lauer-Fields J.L. Fields G.B.
Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 12, 2000-12 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Selective Matrix Metalloproteinase Inhibitors for Cancer
Current Medicinal Chemistry, Vol. 16, Iss. 29, 2009-10 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Cyclooxygenase inhibitors - current status and future prospects
European Journal of Medicinal Chemistry, Vol. 36, Iss. 2, 2001-02 ,pp. :